Kyoto, Japan

Masakazu Hojo


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masakazu Hojo: Innovator in Pharmaceutical Chemistry

Introduction

Masakazu Hojo is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications. His work focuses on innovations that address critical health issues, such as hypertension and ischemic heart diseases.

Latest Patents

Masakazu Hojo holds a patent for "3-Aminocarbonyl-1,4-dihydropyridine-5-carboxylic acid compounds." This patent includes novel compounds that exhibit excellent hypotensive and vasodilating activities. These compounds are useful for the prophylaxis and treatment of hypertension, ischemic heart diseases, and cerebral and peripheral circulation diseases. His innovative approach to these compounds has the potential to improve patient outcomes significantly.

Career Highlights

Hojo is associated with Nippon Shoji Kabushiki Kaisha, where he continues to advance his research and development efforts. His dedication to innovation in pharmaceutical chemistry has positioned him as a key figure in his field. With a focus on creating effective treatments, he has contributed to the scientific community's understanding of important health conditions.

Collaborations

Masakazu Hojo has collaborated with notable colleagues, including Masakatu Hisaki and Kenichi Kashima. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking discoveries in pharmaceutical chemistry.

Conclusion

Masakazu Hojo's contributions to the field of pharmaceutical chemistry are noteworthy, particularly through his innovative patent on 3-aminocarbonyl-1,4-dihydropyridine-5-carboxylic acid compounds. His work continues to have a significant impact on the treatment of critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…